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High rates of Staphylococcus aureus are reported in prosthetic joint infection (PJI) in rheumatoid arthritis (RA). RA patients are
considered to have a high risk of infection with bacteria of potentially oral or dental origin. One thousand four hundred forty-three
revisions for infection were reported to the Norwegian Arthroplasty Register (NAR) from 1987 to 2007. For this study 269 infection
episodes in 255 OA patients served as control group. In the NAR we identiﬁed 49 infection episodes in 37 RA patients from 1987 to
2009. The RA patients were, on average, 10 years younger than the OA patients and there were more females (70% versus 54%). We
found no diﬀerences in the bacterial ﬁndings in RA and OA. A tendency towards a higher frequency of Staphylococcus aureus (18%
versus 11%) causing PJI was found in the RA patients compared to OA. There were no bacteria of potential odontogenic origin
found in the RA patients, while we found 4% in OA. The bacteria identiﬁed in revisions for infection in THRs in patients with RA
did not signiﬁcantly diﬀer from those in OA. Bacteria of oral or dental origin were not found in infected hip joint replacements in
RA.
1. Introduction
Patients with rheumatoid arthritis (RA) often undergo
joint surgery, especially prosthetic joint replacements. In
the prebiological agent era (before 2000), 1-2% of patients
with RA were estimated to need at least one major joint
replacement per year followup [1–4], that is, 25% of the RA
patients with 16–20 years of observation [5, 6].
Prosthetic joint infection (PJI) is a serious although infre-
quent complication to joint replacement surgery. In primary
total hip replacements (THR) the risk of deep infection
is around 1% [7, 8]. A recent study from the Norwegian
Arthroplasty Register (NAR) showed that RA patients had
the same overall risk of PJI as patients with osteoarthritis
in THR, while the risk of revision for infection more than
6 years postoperatively was higher in RA compared to OA
patients [9].
In the present paper we seek to evaluate and compare
bacterial ﬁndings in prosthetic hip joint infections in RA
patients versus OA patients, for the following reasons.
Firstly, PJIs in patients with RA have been reported to be
caused by Staphylococcus aureus (S. aureus) in as much
as 37% [10]. This could be a result of relatively high
carriage rates of S. aureus in RA patients [11–13]. If this
is the case, eradication of nasal S. aureus with intranasal
mupirocin ointment perioperatively might oﬀer an attractive
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opportunity for prevention of postoperative prosthetic joint
infections caused by S. aureus in RA patients undergoing
total hip replacement surgery [14–16].
Secondly, RA patients with indwelling hip- or knee-joint
prostheses are in some international guidelines considered
as exceptional high-risk patients for infections caused by
bacteria of potential dental or oral origin. These patients are
recommended antibiotic prophylaxis to prevent PJI follow-
ing bacteremia caused by dental procedures [17–23]. Other
guidelines and more recent literature do not mention RA as
a high-risk factor and thus do not recommend prophylaxis
[24–29] (Table 1). The aims of this study were to evaluate
the bacterial ﬁndings in PJI among RA patients and compare
them to the ﬁndings in OA patients with PJI. We particularly
focused on the frequency of S. aureus. Furthermore, we
compared the incidence of PJI caused by microorganisms
potentially of oral or dental origin between the groups. This
information might contribute in the discussion as to the need
for treating the RA patient group diﬀerent from those with
OA, concerning antibiotic prophylaxis.
2. Material andMethods
The Norwegian Arthroplasty Register includes information
on patient identiﬁcation, the operating hospital, the reason
for and the type of primary and revision operations as well
as details on the implant type, the ﬁxation method, and
the use of antibiotic prophylaxis in each individual case
[30, 31]. Primarily included in the present study were all
patients having had a PJI leading to a revision, (i.e., surgical
exchange or removal of parts of or the whole prosthesis)
in the period September 15, 1987 until October 2007. The
diagnosis PJI was made by the operating surgeon(s) based
on clinical judgement of the pre- and peroperative ﬁndings
at time of revision surgery, since the registry forms are ﬁlled
in immediately after surgery, and thus before the analysis
of bacterial cultures are ﬁnished. During the study period
107,535 primary total hip replacements were registered.
One thousand four hundred forty-three revision procedures
for infection were reported to the NAR. The ten hospitals
performing most revisions for infection, with a total of 730
revisions, were visited (during the year 2009) by one of
the authors (H.L). In 228 (mean age at revision: 70 years,
56% females) of the infection episodes the medical records
(n = 36), bacterial tests (n = 96), or the surgical data
were incomplete and/or missing (n = 96). Thus, bacterial
test reports and the surgeons’ description of the revision
procedure for a total of 502 episodes were systematically
reviewed (Figure 1). In 215 infection episodes the diagnosis,
that is, indication for primary surgery, was other than OA
or RA, and the major diagnostic groups included acute
fracture, sequelae after dysplasia, sequelae after fractura
colli femoris, M. Pertes/epiphysiolysis, caput necrosis, and
unknown diagnosis. 269 infection episodes were seen in 255
patients with OA and in the present study these served as a
control group.
In the above mentioned cohort 18 infection episodes (14
patients) were observed in patients with RA as the indication
for primary surgery. In the complete NAR database another
1,443 revisions for infection reported to NAR
from 1987–2007





502 revisions for infection
269 in OA patients 18 in RA patients
+31 in RA patients 1987–2009
215 other/unknown
Figure 1: Flow chart showing the inclusion of patients for the study.
23 RA patients that had been revised at 10 hospitals
not originally visited, were found and their records were
obtained. The hospital with most patients was visited by
one of the authors (J. C. Schrama) and the other hospitals
were contacted by mail and asked to submit a copy of the
medical records. A total of 49 infection episodes in 37 RA
patients were thus ﬁnally included (Figure 1). Included in
our analyses were 292 OA and RA patients (mean age at
revision: 72 years, 56% females).
The bacterial ﬁndings were obtained from the micro-
biologic reports in the patient records. Negative cultures
(deep and/or biopsy) taken during revision surgery were
included and one or more positive cultures were considered
as causative for the PJI. We also included bacterial cultures
from joint aspiration or blood cultures on the day of
revision or 1-2 days before revision surgery. Superﬁcial
cultures such as wound swab specimen or swabs from
ﬁstulae were excluded. An infection episode (i.e., revision for
infection) was considered as a new episode if the patient was
assumed clinically free of the former infection and showed
unexpected new symptoms of a PJI. Polymicrobial infections,
here considered as a separate entity, were deﬁned as infec-
tions in which at least two diﬀerent microorganisms were
found. We did not have access to the clinical presentation
of the infections, thus no distinction between potentially
causative organisms and organisms representing secondary
colonisation, could be made. Viridans group streptococci,
beta-haemolytic streptococci, Peptostreptococcus species and
streptococcus-like organisms not further identiﬁed, were
considered microbes of potential oral or dental origin, as
previously described by Berbari et al. [24]. We deﬁned
late infections as infections (i.e., revisions for infection)
occurring more than 3 months after implantation surgery
according to the deﬁnition given by Little et al. [32] and
Fitzgerald et al. [33].
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Table 1: Overview of literature after year 2000 discussing whether rheumatoid arthritis patients are high risk patients for bacteremic
prosthetic joint infection after dental treatment and therefore routinely needing antibiotic prophylaxis.
Authors Year of publication Country RA high risk patients, thus antibiotics
ADA and AAOS [17] 2003 USA Yes
Scott et al. [21] 2005 Australia Yes
Tong and Theis [22] 2008 New Zealand Yes
Kotze [18] 2008 South Africa Yes
Rompen et al. [20] 2008 The Netherlands Yes
AAOS [23] 2009 USA Yes
Kuong et al. [19] 2009 Hong Kong Yes
Seymour et al. [27] 2003 Great Britain No
Uc¸kay et al. [29] 2008 Switzerland No
Blomgren et al. [25, 26] 2009 Sweden No
Berbari et al. [24] 2010 USA No
3. Statistics
Patient characteristics in the RA and OA group were com-
pared using the chi-square test for categorical variables and
the student t-test for continuous variables. The proportion
of a speciﬁc microbe in the RA and the OA group (versus the
proportion of all other cases) were compared using the chi-
square and the Fisher’s exact test. Furthermore, multinomial
logistic regression (results not shown in table) was used to
investigate the relationship between primary diagnosis and
bacterial ﬁndings. Results were calculated as odds ratios (OR)
with 95% CI comparing the groups CoNS, gram negative
bacteria, miscellaneous, mixed ﬂora, and no growth to S.
aureus. Since a total of 26 patients were registered with
more than one revision in the same hip, analyses were also
performed based on the ﬁrst revision only.
Statistical signiﬁcance was deﬁned as a P value less
than 0.05. Preceding power analysis showed that, based on
Berbari’s 10 ﬁndings of 37% frequency of S. aureus in RA
patients our number of observations would achieve 82%
power to reveal as statistically signiﬁcant a 20% diﬀerence in
group proportions.
4. Results
Seventy per cent of patients with RA were females versus 54%
of OA patients (P = 0.06, Table 2). At the time of revision RA
patients were on average 10 years younger than OA patients
(P < 0.001, Table 2). The mean time interval from primary
surgery until revision for infection was 3.8 years for RA
patients and 3.1 years for OA patients (P = 0.3, Table 2).
Staphylococcus aureus was cultured in 9 of the 49 infection
episodes (18%) in RA patients and 30 of 269 episodes (11%)
in OA patients (P = 0.16, Table 3). CoNS tended to be a
more frequent ﬁnding in patients with OA than in those with
RA, although the diﬀerence was not statistically signiﬁcant
(18% RA versus 29% OA, P = 0.11, Table 3). Using
multinomial logistic regression, the odds for culturing CoNS
compared to S. aureus in RA patients was lower than for OA
patients (OR = 0.4, 95% CI: 0.1–1.0, P = 0.06) indicating
that there were more S. aureus compared to CoNS in the
RA group. Including only the ﬁrst revision for infection,
Table 2: Patient characteristics.
RA OA P
Mean age (years) (SD)∗ 64 (16) 74 (8) <0.001
Sex (females%)∗∗ 70% 54% 0.06
Mean time to revision (years)∗ 3.79 3.13 0.3
∗
In 318 infection episodes, ∗∗in the 292 patients.
Table 3: Distribution of cultured bacteria at revision surgery in
infected THR in RA patients versus OA patients.
RA (n = 49) OA (n = 269) P∗
Staphylococcus aureus 9 (18%) 30 (11%) 0.16
Coagulase negative
staphylococci
9 (18%) 79 (29%) 0.11
Streptococci 1 (2%) 19 (7%) 0.33
Enterococci 1 (2%) 18 (7%) 0.33
Gram negative bacteria 3 (6%) 10 (3%) 0.43
Others 1 (2%) 10 (3%) 1.00
Polymicrobial ﬂora 7 (14%) 20 (7%) 0.11
No growth 18 (37%) 83 (31%) 0.42
Bacteria potentially of oral
or dental origin
0 12 (4%) 0.13
∗
Chi-square and Fisher’s exact test.
the diﬀerence was statistically signiﬁcant (OR = 0.3, 95% CI:
0.1–0.9, P = 0.03). Streptococci were cultured in 19 (7%)
of the OA patients and in 1 (2%) RA patient (P = 0.33).
We found no statistically signiﬁcant diﬀerence between the
two patient groups with respect to gram negatives (P =
0.43), enterococci (P = 0.33) and other bacteria (P =
1.00) (Table 3). There was however a tendency towards more
polymicrobial cultures in the RA group (14 versus 7%, P =
0.11). Nor was there any statistically signiﬁcant diﬀerence
in the frequency of infections in which no bacteria were
detected in the culture (P = 0.42). Causative microbes,
potentially of oral or dental origin, were found in 12 (4%)
of the OA and in none of the RA patients (P = 0.13, Table 3).
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5. Discussion
We found no statistically signiﬁcant diﬀerences in the
bacterial ﬁndings of infected THRs in RA compared to
OA patients. Staphylococci were found in more than half
(59.5%) of the positive cultures as reported by others [7, 34].
Mixed or polymicrobial infections had, however, a
tendency to be more frequent in the RA group. This ﬁnding is
in agreement with previous knowledge of wound infections
in immune-altered hosts, in whom polymicrobial micro
ﬂora is more frequently seen, as for example, in patients
with diabetes mellitus [35]. Furthermore, our ﬁnding of a
high percentage of culture negative infections (31–37%) are
caused by prior courses of antimicrobial therapy, inappropri-
ate (handling of the) samples or wrong diagnosis.
Another ﬁnding in the present study was a tendency
towards a higher frequency of S. aureus than, for example,
CoNS in RA patients compared to OA patients, although the
percentage of infections caused by S. aureus was not as high
as 37%, reported by Berbari and coworkers, but in their study
knee as well as hip replacements were included [10]. In the
NAR we have no data on revisions for (early) infections in
which no implant parts were exchanged or removed. Thus we
may have missed some early infections which are frequently
caused by virulent bacteria such as S. aureus.
Eight of the nine S. aureus infections (analyses not
shown) found in the RA patients in the present study
were late infections, that is, revised more than 3 months
postoperatively. RA patients have previously been shown
to be more prone to late infections [9, 36, 37]. These
late, potentially blood-borne infections have, according to
Maderazo et al. [38], skin and soft tissue as the most common
remote sites of infection. S. aureus is generally considered
unlikely to originate from the mouth and were consequently
not included in the group of bacteria of potentially oral or
dental origin, in our study. Several authors however advocate
the possibility of S. aureus originating from the mouth
[39, 40]. Particularly acute or chronic dental infections might
increase the possibility of culturing Staphylococci species
[39].
In the present study we found no signiﬁcant diﬀerence
in the occurrence of microbes potentially of oral or dental
origin in RA patients compared with OA patients, and the
numerical diﬀerence between the groups favoured patients
with RA among whom no patient had such a microorganism
cultured (as opposed to 12 OA patients). Consequently,
our ﬁndings do not support guidelines that RA patients
are high risk patients particularly vulnerable to PJIs caused
by microorganisms after transient bacteremia during dental
procedures. The ﬁndings are in agreement with the existing
policy in Norway which has been that RA patients with
THR are not given prophylactic antibiotics before dental
treatment.
A strength of this study is that it includes data selected
from a national registry comprising an entire country (4.8
million inhabitants) over a period of more than 20 years.
Data completeness for hip replacements has been shown to
be very good, even for revision operations [41]. Although a
large RA cohort has been studied previously (200 infection
episodes, Berbari et al. [10]), our material is unique in
terms of the comparison of microbiology in one of the
largest cohorts of RA and OA patients. A drawback is the
insuﬃcient statistical power of the study. A P value in
the nonsigniﬁcant range can either reﬂect an actual lack
of diﬀerence between the patient groups or that there are
too few observations to demonstrate such a diﬀerence, if
existent. Reported ﬁndings should be interpreted with this
in mind. Our power calculation was based on the ﬁndings
of Berbari et al. [10] In their material of 200 infection
episodes from the prebiological agents era 37% S. aureus
was seen in PJIs in patients with RA. We found only 18% S.
aureus in our material and consequently, there were too few
infection episodes in our RA patients to detect a statistically
signiﬁcant diﬀerence for S. aureus (if present). On the other
hand our material is, to our knowledge, one of the largest
microbiological materials including and comparing RA and
OA patients. Another drawback is the large number of
infection episodes with missing or wrong data (228 of 730).
Although not analysed, we have no reason to believe that
these exclusions represent any kind of selection bias.
Furthermore, patients with PJIs treated solely by con-
servative means or those treated with limited surgical
procedures (not involving removal or exchange of prosthetic
parts) were not reported to the registry, and thus were not
evaluated in this study.
Finally, we had no information on the patients’ medi-
cation, which might have had an inﬂuence on the micro-
biology. For instance, immune-modulating antirheumatic
medication may increase the risk of infection caused by low-
virulent microbes.
6. Conclusion
We found no diﬀerences in the microbiology of infected
THRs in RA patients compared to OA patients. There tended
to be an increased risk of PJIs caused by S. aureus in
RA patients, but we did not conﬁrm the high rates of S.
aureus previously reported in RA. Whether or not there is
reason to advise the use of intranasal mupirocine ointment
perioperatively as prophylactic strategy against S. aureus in
PJI’s may still be a matter of discussion, but we found no
reason to treat the RA group diﬀerently in this respect.
Furthermore, RA patients seemed less, rather than more,
prone to PJIs caused by potentially oral or dental microbes
when compared to OA patients. Consequently we cannot,
on the basis of our ﬁndings, recommend a diﬀerent policy
regarding antibiotic prophylaxis prior to dental treatment in
RA patients. RA patients should be individually evaluated
with particular emphasis on the patient’s comorbidities and
medication [25–27]. We advise to continue the common
praxis in Norway not giving routinely antibiotic prophylaxis
before dental procedures.
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